Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNdXNlT2JONFFqbVlvbHRJQlRZQkc4MXFjcGlobnVyYklCZzlKdnpQMkYtaUp4enVqVGNUTjZ6SWJMLW5XWjB2Wk1YZ2tMTm42Mi1pVDVYcUI4ZGRRTkJ3bWtETmxWejNHd3pqbWVjMUxMN3JCM05aa1ZoTkszNEdMUXZYc202Uk80QzFkcUNyZVJjM2ZLM01uZDNHeTlZTXlXOEFmS2Q2WWc2OG5KR3Q5M3pyQVpCYTd5M3JwclZUMVlNSE1ZeHJXc1pEelpoQ2xaQ2Rxbl9wa2pOeTM2ZFE?oc=5" target="_blank">Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports</a> <font color="#6f6f6f">Reuters</font>
Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, ending a dispute that escalated into a legal battle last month.
Similar Stories
Related coverage based on topic and tags
Uber weighs higher bid for Delivery Hero, FT reports - Reuters
Uber weighs higher bid for Delivery Hero, FT reports Reuters
May 24, 2026 at 08:16 PMDelivery Hero confirms takeover offer from Uber - Reuters
Delivery Hero confirms takeover offer from Uber Reuters
May 23, 2026 at 02:36 PMDelivery Hero shares surge to 18-month high as Uber eyes takeover - Reuters
Delivery Hero shares surge to 18-month high as Uber eyes takeover Reuters
May 25, 2026 at 10:16 AMUber and DoorDash sound out investors for Delivery Hero bid, FT reports - Reuters
Uber and DoorDash sound out investors for Delivery Hero bid, FT reports Reuters
May 23, 2026 at 01:38 PMLululemon ends proxy battle with founder Chip Wilson - Reuters
Lululemon ends proxy battle with founder Chip Wilson Reuters
May 27, 2026 at 12:56 PMBollore urges UMG to reject Ackman's $64 billion bid - Reuters
Bollore urges UMG to reject Ackman's $64 billion bid Reuters
May 27, 2026 at 11:05 AM